Active, Not Recruiting
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
NCT02143726
- Conditions
- Refractory Hurthle Cell Thyroid Cancer, Thyroid cancer, Hurthle cell
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Siouxland Regional Cancer Center Sioux City, Iowa, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States